Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-Agent: * |
Title | AAVogen, Inc. – We make you |
Description | AAVogen, Inc. We make you stronger Home About Us Pipeline Disease Indications FAQ Investing Media An end to muscle wasting Gene therapeutics to strengthen |
Keywords | N/A |
WebSite | aavogen.com |
Host IP | 198.71.233.87 |
Location | United States |
Site | Rank |
US$1,825,487
Last updated: 2023-05-12 03:47:30
aavogen.com has Semrush global rank of 5,798,073. aavogen.com has an estimated worth of US$ 1,825,487, based on its estimated Ads revenue. aavogen.com receives approximately 210,634 unique visitors each day. Its web server is located in United States, with IP address 198.71.233.87. According to SiteAdvisor, aavogen.com is safe to visit. |
Purchase/Sale Value | US$1,825,487 |
Daily Ads Revenue | US$1,686 |
Monthly Ads Revenue | US$50,552 |
Yearly Ads Revenue | US$606,624 |
Daily Unique Visitors | 14,043 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
aavogen.com. | A | 599 | IP: 198.71.233.87 |
aavogen.com. | NS | 3600 | NS Record: ns05.domaincontrol.com. |
aavogen.com. | NS | 3600 | NS Record: ns06.domaincontrol.com. |
aavogen.com. | MX | 3600 | MX Record: 0 aavogen-com.mail.protection.outlook.com. |
aavogen.com. | TXT | 3600 | TXT Record: v=spf1 include:secureserver.net -all |
aavogen.com. | TXT | 3600 | TXT Record: NETORGFT2381567.onmicrosoft.com |
AAVogen, Inc. We make you stronger Home About Us Pipeline Disease Indications FAQ Investing Media An end to muscle wasting Gene therapeutics to strengthen muscle and fight disease AVGN7 Gene therapy AAV vectors are the holy grail of gene therapy. These viral tools introduce "payload genes" into different tissues often with great precision. They do not cause disease and have a proven safety record in clinical trials. Thus, their use has the potential to provide safe and long-term relief for genetic and/or chronic diseases. Learn More Strong healthy muscle AAVogen is developing a gene therapy for muscle wasting diseases, especially inclusion body myositis, Duchenne muscular dystrophy and cancer cachexia. In pre-clinical studies, AVGN7 stabilizes muscle structure and increases muscle mass, strength and exercise capacity. It also prevents muscle wasting. Learn More Strong healthy hearts Cardiac and skeletal muscle wasting go hand-in-hand. Indeed, addressing cardiac and respiratory failure |
HTTP/1.1 200 OK Accept-Ranges: bytes Age: 60284 Content-Length: 38828 Content-Type: text/html; charset=UTF-8 Date: Fri, 26 Nov 2021 15:57:16 GMT Vary: Accept-Encoding, User-Agent X-Backend: local X-Cache: cached X-Cache-Hit: HIT X-Cacheable: YES:Forced X-Content-Type-Options: nosniff X-Xss-Protection: 1; mode=block |
Domain Name: AAVOGEN.COM Registry Domain ID: 1948697139_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-07-24T18:53:57Z Creation Date: 2015-07-23T18:17:22Z Registry Expiry Date: 2023-07-23T18:17:22Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS05.DOMAINCONTROL.COM Name Server: NS06.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-08T18:27:11Z <<< |